Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VETtiPAT-ARF: VET-guided tPA in ARF
NCT05540834Phase 2Recruiting
- Sponsor
- South Western Sydney Local Health District
- Start
- May 2022
- Primary completion
- May 2026
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of tissue-plasminogen activator in acute respiratory failure (ARF), sponsored by South Western Sydney Local Health District. Started May 2022; status: recruiting.
02
Drugs
tissue-plasminogen activator
03
Conditions
acute respiratory failure (ARF)
Beyond the preview
Go deeper on NCT05540834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05540834.